期刊文献+

心理干预对乳腺癌患者焦虑情绪影响的观察

Effect of Psychological Intervention on Anxiety of Breast Cancer Patients
下载PDF
导出
摘要 目的观察心理干预对围手术期乳腺癌患者焦虑情绪的影响。方法通过对住院的乳腺癌围手术期患者进行Zung焦虑自评表(SAS)评估,在护理方面实施心理干预,观察干预前后的效果。结果心理干预前后焦虑情绪对比,干预后患者的焦虑评分明显下降,115例乳腺癌女性患者心理干预前,SAS评估为(60.25±17.81)分,给予心理干预后SAS评估为(48.35±15.66)分,干预前后比较(P<0.01)差异有统计学意义。结论心理干预对围手术期乳腺癌患者焦虑情绪的改善有着积极的意义。 Objective To observe the effect of psychological intervention on breast cancer patients during the peri operation anxiety.Methods The patients in breast cancer during operation period of Zung self rating Anxiety Scale(SAS)assessment,psychological intervention in nursing,were observed before and after the intervention ef ect.Results Before and after psychological intervention anxiety contrast,after the intervention,patients'anxiety score decreased obviously,115 cases of breast cancer in female patients before intervention,SAS evaluates to 60.25+17.81,the given psychological intervention SAS evaluates to 48.35+15.66,before and after the intervention(P<0.01)with statistical y significant dif erence.Conclusion There is a positive meaning to improve the psychological intervention on breast cancer patients during the peri operation anxiety.
作者 雷晓红 LEI Xiao-hong(Hechuan District People's Hospital,Chongqing 401520,China)
机构地区 合川区人民医院
出处 《医学信息(医学与计算机应用)》 2014年第12期161-161,共1页 Medical Information
关键词 乳腺癌患者 焦虑 心理干预 Breast cancer patients Anxiety Psychological intervention
  • 相关文献

参考文献2

二级参考文献14

  • 1柯元南.慢性心力衰竭诊治新进展[J].中国全科医学,2007,10(6):433-434. 被引量:35
  • 2Chung P, Hermann L. Acute decompensated heart failure : formulating an evidence-based approach to diagnosis and treatment ( part I ) [ J ]. Mt Sinai J Med,2006,73 (2) :506-515.
  • 3Kapoor JR, Perazella MA. Diagnostic and therapeutic approach to acute decompensated heart failure [ J ]. Am J Med,2007,120 ( 2 ) : 121-127.
  • 4Keating GM, Goa KL. Nesiritide : a review of its use in acute decom- pensated heart failure[ J]. Drugs,2003,63( 1 ) :47-70.
  • 5Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides[ J]. Am J Cardiol,2008,101 ( Suppl A) :3A-8A.
  • 6Diekstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 : the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology [ J ]. Eur Heart J,2008,10(10) :933-989.
  • 7Moe GW, Howlett J ,Januzzi JL, et al. N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected a- cute heart failure:primary results of the Canadian prospective random- ized multicenter IMPROVE-CHF study [ J ]. Circulation, 2007, 115 (24) :3103-3110.
  • 8Januzzi JL, Van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart fail- ure :an international pooled analysis of 1256 patients:the Intemational Collaborative of NT-proBNP Study [ J ]. Eur Heart J, 2006,27 ( 3 ) : 330-337.
  • 9Krum H, Liew D. New and emerging drug therapies for the manage- ment of acute heart failure [ J ]. Intern Med J, 2003,33 ( 11 ) : 515 -520.
  • 10Steiner J, Guglin M. BNP or NTproBNP? A clinician' s perspective [J]. Int J Cardiol,2008,129( 1 ) :5-14.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部